Search

Your search keyword '"Frerker C"' showing total 265 results
Start Over Author "Frerker C"

Refine your results

more »

more »

more »
265 results on '"Frerker C"'

2. Analgosedierung in der Kardiologie Konsensuspapier der DGK und DGAI 2024.

Author

Tilz, R. R., Busch, S., Chun, K. R. J., Frerker, C., Gaede, L., Steven, D., Tiefenbacher, C., Eckardt, L., Sander, M., Zwißler, B., Wappler, F., von Dossow, V., and Thiele, H.

Subjects
TRANSESOPHAGEAL echocardiography, CONSENSUS (Social sciences), PATIENT safety, SURGICAL therapeutics, ANALGESICS, ATRIAL fibrillation, IMPLANTABLE cardioverter-defibrillators, PAIN management, CARDIAC pacemakers, CATHETER ablation, HUMAN comfort, ELECTROPHYSIOLOGY, ANESTHESIA
Abstract

Copyright of Anaesthesiologie & Intensivmedizin is the property of DGAI e.V. - Deutsche Gesellschaft fur Anasthesiologie und Intensivmedizin e.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2024
Full Text
View/download PDF

3. Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)

Author

Hohmann, C, primary, Pfister, R, additional, Frerker, C, additional, Beckmann, A, additional, Walther, T, additional, Bleiziffer, S, additional, Ensminger, S, additional, Bekeredjian, R, additional, Seiffert, M, additional, Sinning, J M, additional, Moellmann, H, additional, Beyersdorf, F, additional, Herrmann, E, additional, Balaban, Ü, additional, and Kuhn, E W, additional

Published
2023
Full Text
View/download PDF

11. TAVI versus SAVR in intermediate-risk patients with severe aortic stenosis and chronic kidney disease: a matched comparison in a subcohort from the GARY registry

Author

Mas-Peiro, S, primary, Faerber, G, additional, Herrmann, E, additional, Bauer, T, additional, Bleiziffer, S, additional, Bekeredjian, R, additional, Boening, A, additional, Frerker, C, additional, Beckmann, A, additional, Moellmann, H, additional, Ensminger, S, additional, Hamm, C, additional, Beyersdorf, F, additional, Fichtlscherer, S, additional, and Walther, T, additional

Published
2022
Full Text
View/download PDF

14. Surgical Aortic Valve Replacement in Patients Aged 50 to 69 Years: Insights from the German Aortic Valve Registry (GARY)

Author

Vogt, F., additional, Santarpino, G., additional, Fujita, B., additional, Frerker, C., additional, Bauer, T., additional, Bekeredjian, R., additional, Bleiziffer, S., additional, Beckmann, A., additional, Möllmann, H., additional, Walther, T., additional, Beyersdorf, F., additional, Hamm, C., additional, Böning, A., additional, Baldus, S., additional, Ensminger, S., additional, Fischlein, T., additional, and Eckner, D., additional

Published
2022
Full Text
View/download PDF

15. Refined prediction and validation of individual risk using machine learning in transcatheter aortic valve implantation: TAVI Risk Machine (TRIM) scores

Author

Leha, A, primary, Huber, C, additional, Friede, T, additional, Bauer, T, additional, Beckmann, A, additional, Bekeredjian, R, additional, Bleiziffer, S, additional, Herrmann, E, additional, Moellmann, H, additional, Walther, T, additional, Kutschka, I, additional, Hasenfuss, G, additional, Ensminger, S, additional, Frerker, C, additional, and Seidler, T, additional

Published
2021
Full Text
View/download PDF

17. Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience

Author

Armario, X., Rosseel, L., Kharbanda, R., Khogali, S., Abdel-Wahab, M., Van Mieghem, N. M., Tchetche, D., Dumonteil, N., De Backer, O., Cotton, J., Mcgrath, B., Balakrishnan, D., Ali, N., Farhan, S., Joseph, J., Charbonnier, G., Okuno, T., Mchugh, F., Hildick-Smith, D., Gilgen, N., Hokken, T., Spence, M. S., Frerker, C., Angelillis, M., Grygier, M., Cockburn, J., Bjursten, H., Jeger, R. V., Teles, R., Petronio, A. S., Pilgrim, T., Sinning, J. -M., Nickenig, G., Sondergaard, L., Blackman, D. J., Mylotte, D., and Cardiology

Subjects
Europe, Transcatheter Aortic Valve Replacement, Treatment Outcome, aortic valve stenosis, transcatheter aortic valve replacement, transcatheter heart valve, Aortic Valve, Humans, Prosthesis Design, Retrospective Studies, Risk Factors, Aortic Valve Stenosis, Heart Valve Prosthesis, 610 Medicine & health
Abstract

OBJECTIVES The aim of this study was to evaluate the short-term safety and efficacy of transcatheter aortic valve replacement (TAVR) with the LOTUS Edge system. BACKGROUND The LOTUS Edge system was commercially re-released in April 2019. The authors report the first European experience with this device. METHODS A multicenter, single-arm, retrospective registry was initiated to evaluate short-term clinical outcomes. Included cases are the first experience with this device and new implantation technique in Europe. Clinical, echocardiographic, and computed tomographic data were analyzed. Endpoints were defined according to Valve Academic Research Consortium-2 and were site reported. RESULTS Between April and November 2019, 286 consecutive patients undergoing TAVR with the LOTUS Edge system at 18 European centers were included. The mean age and Society of Thoracic Surgeons score were 81.2 �� 6.9 years and 5.2 �� 5.4%, respectively. Nearly one-half of all patients (47.9%) were considered to have complex anatomy. Thirty-day major adverse events included death (2.4% [n��=��7]) and stroke (3.5% [n��=��10]). After TAVR, the mean aortic valve area was 1.9 �� 0.9��cm2, and the mean transvalvular gradient was 11.9 �� 5.7��mm��Hg. None or trace paravalvular leak (PVL) occurred in 84.4% and moderate PVL in 2.0%. There were no cases of severe PVL. New permanent pacemaker (PPM) implantation was required in 25.9% among all patients and 30.8% among PPM-naive patients. CONCLUSIONS Early experience with the LOTUS Edge system demonstrated satisfactory short-term safety and efficacy, favorable hemodynamic data, and very low rates of PVL in an anatomically complex cohort. New PPM implantation remained high. Further study will evaluate if increasing operator experience with the device and new implantation technique can reduce the incidence of PPM implantation.

Published
2021

20. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry

Author

Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Louriero R, Fam N, Frerker C, Ho E, Juliard JM, Kaple R, Kodali S, Kreidel F, Kuck KH, Lauten A, Lurz J, Monivas V, Mehr M, Nazif T, Nickening G, Pedrazzini G, Praz F, Puri R, Rodes-Cabau J, Schafer U, Schofer J, Sievert H, Tang GHL, Khattab AA, Thiele H, Unterhuber M, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Hausleiter J, Lurz P, Maisano F, Leon MB, Hahn RT, Taramasso, M, Gavazzoni, M, Pozzoli, A, Alessandrini, H, Latib, A, Attinger-Toller, A, Biasco, L, Braun, D, Brochet, E, Connelly, Ka, de Bruijn, S, Denti, P, Deuschl, F, Estevez-Louriero, R, Fam, N, Frerker, C, Ho, E, Juliard, Jm, Kaple, R, Kodali, S, Kreidel, F, Kuck, Kh, Lauten, A, Lurz, J, Monivas, V, Mehr, M, Nazif, T, Nickening, G, Pedrazzini, G, Praz, F, Puri, R, Rodes-Cabau, J, Schafer, U, Schofer, J, Sievert, H, Tang, Ghl, Khattab, Aa, Thiele, H, Unterhuber, M, Vahanian, A, Von Bardeleben, R, Webb, Jg, Weber, M, Windecker, S, Winkel, M, Zuber, M, Hausleiter, J, Lurz, P, Maisano, F, Leon, Mb, and Hahn, Rt

Subjects
Male, Cardiac Catheterization, Pacemaker, Artificial, Time Factors, Clinical Decision-Making, Electric Countershock, Prosthesis Design, Postoperative Complications, Risk Factors, Humans, Hospital Mortality, Registries, 610 Medicine & health, Retrospective Studies, Aged, 80 and over, Heart Valve Prosthesis Implantation, Cardiac Pacing, Artificial, Hemodynamics, Mitral Valve Insufficiency, Recovery of Function, Defibrillators, Implantable, Europe, Treatment Outcome, Heart Valve Prosthesis, North America, Feasibility Studies, Mitral Valve, Female
Abstract

OBJECTIVES The interference of a transtricuspid cardiac implantable electronic device (CIED) lead with tricuspid valve function may contribute to the mechanism of tricuspid regurgitation (TR) and poses specific therapeutic challenges during transcatheter tricuspid valve intervention (TTVI). Feasibility and efficacy of TTVI in presence of a CIED is unclear. BACKGROUND Feasibility of TTVI in presence of a CIED lead has never been proven on a large basis. METHODS The study population consisted of 470 patients with severe symptomatic TR from the TriValve (Transcatheter Tricuspid Valve Therapies) registry who underwent TTVI at 21 centers between 2015 and 2018. The association of CIED and outcomes were assessed. RESULTS Pre-procedural CIED was present in 121 of 470 (25.7%) patients. The most frequent location of the CIED lead was the posteroseptal commissure (44.0%). As compared with patients without a transvalvular lead (no-CIED group), patients having a tricuspid lead (CIED group) were more symptomatic (New York Heart Association functional class III to IV in 95.9% vs. 92.3%; p = 0.02) and more frequently had previous episodes of right heart failure (87.8% vs. 69.0%; p = 0.002). No-CIED patients had more severe TR (effective regurgitant orifice area 0.7 ± 0.6 cm2 vs. 0.6 ± 0.3 cm2; p = 0.02), but significantly better right ventricular function (tricuspid annular plane systolic excursion = 16.7 ± 5.0 mm vs. 15.9 ± 4.0 mm; p = 0.04). Overall, 373 patients (79%) were treated with the MitraClip (Abbott Vascular, Santa Clara, California) (106 [87.0%] in the CIED group). Among them, 154 (33%) patients had concomitant transcatheter mitral repair (55 [46.0%] in the CIED group, all MitraClip). Procedural success was achieved in 80.0% of no-CIED patients and in 78.6% of CIED patients (p = 0.74), with an in-hospital mortality of 2.9% and 3.7%, respectively (p = 0.70). At 30 days, residual TR ≤2+ was observed in 70.8% of no-CIED and in 73.7% of CIED patients (p = 0.6). Symptomatic improvement was observed in both groups (NYHA functional class I to II at 30 days: 66.0% vs. 65.0%; p = 0.30). Survival at 12 months was 80.7 ± 3.0% in the no-CIED patients and 73.6 ± 5.0% in the CIED patients (p = 0.30). CONCLUSIONS TTVI is feasible in selected patients with CIED leads and acute procedural success and short-term clinical outcomes are comparable to those observed in patients without a transtricuspid lead.

Published
2019

21. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

Author

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS, Jr., Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR, Yoon, Sh, Whisenant, Bk, Bleiziffer, S, Delgado, V, Dhoble, A, Schofer, N, Eschenbach, L, Bansal, E, Murdoch, Dj, Ancona, M, Schmidt, T, Yzeiraj, E, Vincent, F, Niikura, H, Kim, Wk, Asami, M, Unbehaun, A, Hirji, S, Fujita, B, Silaschi, M, Tang, Ghl, Kuwata, S, Wong, Sc, Frangieh, Ah, Barker, Cm, Davies, Je, Lauten, A, Deuschl, F, Nombela-Franco, L, Rampat, R, Nicz, Pfg, Masson, Jb, Wijeysundera, Hc, Sievert, H, Blackman, Dj, Gutierrez-Ibanes, E, Sugiyama, D, Chakravarty, T, Hildick-Smith, D, de Brito, F, J, R., Jensen, C, Jung, C, Smalling, Rw, Arnold, M, Redwood, S, Kasel, Am, Maisano, F, Treede, H, Ensminger, Sm, Kar, S, Kaneko, T, Pilgrim, T, Sorajja, P, Van Belle, E, Prendergast, Bd, Bapat, V, Modine, T, Schofer, J, Frerker, C, Kempfert, J, Attizzani, Gf, Latib, A, Schaefer, U, Webb, Jg, Bax, Jj, and Makkar, Rr

Published
2019

24. Clinical outcomes after surgical or transcatheter aortic valve replacement in patients with chronic kidney disease: an analysis in 29 893 patients from the German Aortic Valve Registry

Author

Mas-Peiro, S, primary, Faerber, G, additional, Bauer, T, additional, Bleiziffer, S, additional, Bekeredjian, R, additional, Boening, A, additional, Frerker, C, additional, Beckmann, A, additional, Moellmann, H, additional, Vasa-Nicotera, M, additional, Ensminger, S, additional, Hamm, C.W, additional, Beyersdorf, F, additional, Walther, T, additional, and Fichtlscherer, S, additional

Published
2020
Full Text
View/download PDF

25. Transcatheter aortic valve implantation with the LOTUS Edge system: early European experience

Author

Armario, X, primary, Rosseel, L, additional, Banning, A, additional, Khogali, S.S, additional, Blackman, D.J, additional, Abdel-Wahab, M.S, additional, Tchetche, D, additional, Hildick-Smith, D, additional, Van Mieghem, N.M, additional, Spence, M.S, additional, Frerker, C, additional, Nickenig, G, additional, Pilgrim, T, additional, Sondergaard, L, additional, and Mylotte, D, additional

Published
2020
Full Text
View/download PDF

26. Pulmonary hypertension and valvular heart disease

Author

Tichelbaecker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wissmueller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., Baldus, S., Rosenkranz, S., Tichelbaecker, T., Dumitrescu, D., Gerhardt, F., Stern, D., Wissmueller, M., Adam, M., Schmidt, T., Frerker, C., Pfister, R., Halbach, M., Baldus, S., and Rosenkranz, S.

Abstract

Pulmonary hypertension (PH) is an important contributor to morbidity and mortality in patients with left-sided heart disease, including valvular heart disease. In this context, elevated left atrial pressure primarily leads to the development of post-capillary PH. Despite the fact that repair of left-sided valvular heart disease by surgical or interventional approaches will improve PH, recent studies have highlighted that PH (pre- or post-interventional) remains an important predictor of long-term outcome. Here, we review the current knowledge on PH in valvular heart disease taking into account new hemodynamic PH definitions, and the distinction between post- and pre-capillary components of PH. A specific focus is on the precise characterization of hemodynamics and cardiopulmonary interaction, and on potential strategies for the management of residual PH after mitral or aortic valve interventions. In addition, we highlight the clinical significance of tricuspid regurgitation, which may occur as a primary condition or as a consequence of PH and right heart dilatation (functional). In this context, proper patient selection for potential tricuspid valve interventions is crucial. Finally, the article highlights gaps in evidence, and points toward future perspectives.

Published
2019

27. Cardioband (R): Where do we stand, who are suitable patients?

Author

Frerker, C., Schmidt, T., Pfister, R., Koerber, M. I., Mauri, V., Woesten, M., Baldus, S., Frerker, C., Schmidt, T., Pfister, R., Koerber, M. I., Mauri, V., Woesten, M., and Baldus, S.

Abstract

Functional mitral regurgitation (FMR) is characterized by a dilatation of the mitral valve annulus resulting in an insufficient adaptation of the anterior and posterior mitral valve leaflets and/or severe tethering of the leaflets due to dilatation of the left ventricle. The Cardioband (R) system was introduced in 2015 and is a catheter-based direct mitral valve annuloplasty procedure for treatment of FMR. In the European CE approval study 60 patients with moderate or severe FMR were analyzed per protocol. There were no device or procedure-related deaths. The technical success rate of the procedure, defined as successful implantation and tightening was 97%. At 1 year, the overall survival and survival free of hospital readmission for heart failure were 87% and 66%, respectively. Currently, various interventional treatment procedures are available, such as the edge-to-edge technique as well as direct and indirect annuloplasty. In summary, patients with FMR as a result of a dilatation of the mitral valve annulus appear to be suitable for direct annuloplasty with the Cardioband (R) system.

Published
2019

30. The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?

Author

Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard JM, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schafer U, Schofer J, Schueler R, Tang G, Vahanian A, Webb JG, Yzeiraj E, Maisano F, Leon MB, Taramasso, M, Hahn, Rt, Alessandrini, H, Latib, A, Attinger-Toller, A, Braun, D, Brochet, E, Connelly, Ka, Denti, P, Deuschl, F, Englmaier, A, Fam, N, Frerker, C, Hausleiter, J, Juliard, Jm, Kaple, R, Kreidel, F, Kuck, Kh, Kuwata, S, Ancona, M, Malasa, M, Nazif, T, Nickenig, G, Nietlispach, F, Pozzoli, A, Schafer, U, Schofer, J, Schueler, R, Tang, G, Vahanian, A, Webb, Jg, Yzeiraj, E, Maisano, F, and Leon, Mb

Published
2017

33. Incidence of new Permanent Pacemaker Implantation after Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Implantation and Its Impact on 1-Year Mortality—Insights from the German Aortic Valve Registry

Author

Fujita, B., additional, Schmidt, T., additional, Bleiziffer, S., additional, Bauer, T., additional, Beckmann, A., additional, Bekeredjian, R., additional, Möllmann, H., additional, Walther, T., additional, Landwehr, S., additional, Hamm, C., additional, Beyersdorf, F., additional, Katus, H., additional, Harringer, W., additional, Ensminger, S., additional, and Frerker, C., additional

Published
2019
Full Text
View/download PDF

35. 2117Cerebral protection during catheter ablation of ventricular tachycardia in patients with ischemic heart disease

Author

Heeger, C H, primary, Metzner, A, additional, Schlueter, M, additional, Rillig, A, additional, Mathew, S, additional, Fink, T, additional, Reissmann, B, additional, Lemes, C, additional, Maurer, T, additional, Santoro, F, additional, Schmidt, T, additional, Ghanem, A, additional, Frerker, C, additional, Kuck, K H, additional, and Ouyang, F, additional

Published
2018
Full Text
View/download PDF

37. 997Embolic debris captured by a cerebral protection system during catheter ablation of ventricular tachycardia in patients with ischemic heart disease

Author

Heeger, C H, primary, Metzner, A, additional, Rillig, A, additional, Mathew, S, additional, Fink, T, additional, Reissmann, B, additional, Lemes, C, additional, Maurer, T, additional, Santoro, F, additional, Schmidt, T, additional, Frerker, C, additional, Ghanem, A, additional, Kuck, K H, additional, and Ouyang, F, additional

Published
2018
Full Text
View/download PDF

38. P1212The clip and the tip: Long-term clinical outcome after ablation of atrial fibrillation in patients with MitraClip

Author

Rottner, L, primary, Schmidt, T, additional, Dotz, I, additional, Lemes, C, additional, Heeger, C H, additional, Fink, T, additional, Mathew, S, additional, Reissmann, B, additional, Rexha, E, additional, Riedl, J, additional, Frerker, C, additional, Ouyang, F, additional, Kuck, K H, additional, Metzner, A, additional, and Maurer, T, additional

Published
2018
Full Text
View/download PDF

39. Direct Comparison of Rapid Deployment Valves and Conventional Biological Valves for Treatment of Aortic Stenosis: Insights from the German Aortic Valve Registry

Author

Ensminger, S., additional, Fujita, B., additional, Bauer, T., additional, Möllmann, H., additional, Beckmann, A., additional, Bekeredjian, R., additional, Bleiziffer, S., additional, Landwehr, S., additional, Hamm, C., additional, Mohr, F.-W., additional, Katus, H., additional, Harringer, W., additional, Walther, T., additional, and Frerker, C., additional

Published
2018
Full Text
View/download PDF

40. Conscious Sedation versus General Anesthesia in Transcatheter Aortic Valve Implantation: Insights from the German Aortic Valve Registry

Author

Fujita, B., additional, Husser, O., additional, Hengstenberg, C., additional, Beckmann, A., additional, Möllmann, H., additional, Walther, T., additional, Bekeredjian, R., additional, Bleiziffer, S., additional, Mohr, F.-W., additional, Bauer, T., additional, Ensminger, S., additional, and Frerker, C., additional

Published
2018
Full Text
View/download PDF

41. Treatment of Native Calcific Mitral Stenosis using Commercially Available Transcatheter Heart Valves (THV): Results from the First German THV Mitral Stenosis Registry

Author

Schirmer, J., additional, Holzhey, D., additional, Sinning, J.M., additional, Bauernschmitt, R., additional, Schröfel, H., additional, Oertel, F., additional, Bleiziffer, S., additional, Unbehaun, A., additional, Holinski, S., additional, Lauten, A., additional, Frerker, C., additional, Kaminski, A., additional, Blankenberg, S., additional, Reichenspurner, H., additional, Conradi, L., additional, and Schäfer, U., additional

Published
2017
Full Text
View/download PDF

43. SAPIEN 3 implantation in failed surgical aortic bioprostheses: Matched comparison and Insights from the Valve-in-Valve International Data (VIVID) Registry

Author

Seiffert, M., Treede, H., Himbert, D., Kodali, S., Jochheim, D., Mehilli, J., Santos, M.S. dos, Linke, A., Woitek, F., Weisz, G., Bapat, V., Lim, Z.Y., Tchetche, D., Bleiziffer, S., Walther, T., Barbanti, M., Eltchaninoff, H., Durand, E., Buz, S., Frerker, C., Windecker, S., Abdel-Wahab, M., Spargias, K., Weger, A. de, Feuchtner, G., John, W., and Dvir, D.

Subjects
TAVI, Valve-in-valve, TAVR
Published
2015

44. Up to 1-year follow-up results from a multi-centre trial of a novel percutaneous mitral annuloplasty system

Author

Kuck, K. -H., Nickenig, G., Hammerstingl, C., Vahanian, A., Messika-Zeitoun, D., Frerker, C., Alfieri, O., Colombo, A., Latib, A., Baldus, S., Rudolph, V., Topilsky, Y., Grayburn, P., Maisano, F., Kuck, K. -H., Nickenig, G., Hammerstingl, C., Vahanian, A., Messika-Zeitoun, D., Frerker, C., Alfieri, O., Colombo, A., Latib, A., Baldus, S., Rudolph, V., Topilsky, Y., Grayburn, P., and Maisano, F.

Published
2016

45. Use of Endovascular Dual Filtration System for Cerebral Protection in Transcatheter Heart Valve Implantation Procedures

Author

Deuschl, F., primary, Schofer, N., additional, Vogel, B., additional, Seiffert, M., additional, Frerker, C., additional, Conradi, L., additional, Treede, H., additional, Lubos, E., additional, Schirmer, J., additional, Schewel, D., additional, Kuck, K.-H., additional, Reichenspurner, H., additional, Blankenberg, S., additional, and Schäfer, U., additional

Published
2016
Full Text
View/download PDF

46. Sutureless Aortic Valve Replacement: How to Reduce the Risk of Postoperative Conduction Disorders and Pacemaker Implants.

Author

Ensminger, S., Fujita, B., Bauer, T., Möllmann, H., Beckmann, A., Bekeredjian, R., Bleiziffer, S., Landwehr, S., Hamm, C., Mohr, F.-W., Katus, H., Harringer, W., Walther, T., and Frerker, C.

Subjects
AORTIC valve surgery, HEART conduction system, CARDIAC pacemakers, PROSTHETIC heart valves, ATRIOVENTRICULAR node, DISEASES, SURGERY
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results